PMC6098839_01
Objective partial response in the left external iliac lymph nodes. (Left) Before treatment with pembrolizumab. (Right) After four cycles of pembrolizumab
40661_2018_63_Fig1_HTML.jpg
PMC6098839_01_40661_2018_63_Fig1_HTML.jpg
Fig1
After the fourth cycle, PET/CT showed objective partial response in the left external iliac lymph nodes (Fig. 1), as well as in the right-posterior pectoral lymph node conglomerate (Fig. 2).